BlackRock’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$349 Hold
296
﹤0.01% 5312
2025
Q1
$639 Hold
296
﹤0.01% 5301
2024
Q4
$838 Hold
296
﹤0.01% 5261
2024
Q3
$1.82K Hold
296
﹤0.01% 5060
2024
Q2
$1.63K Hold
296
﹤0.01% 5136
2024
Q1
$1.07K Hold
296
﹤0.01% 5141
2023
Q4
$2.12K Sell
296
-28
-9% -$200 ﹤0.01% 5164
2023
Q3
$829 Sell
324
-130
-29% -$333 ﹤0.01% 5272
2023
Q2
$1.14K Sell
454
-91,261
-100% -$228K ﹤0.01% 5310
2023
Q1
$213K Hold
91,715
﹤0.01% 4669
2022
Q4
$164K Buy
91,715
+1
+0% +$2 ﹤0.01% 4820
2022
Q3
$239K Hold
91,714
﹤0.01% 4843
2022
Q2
$263K Sell
91,714
-27,324
-23% -$78.4K ﹤0.01% 4874
2022
Q1
$964K Sell
119,038
-858
-0.7% -$6.95K ﹤0.01% 4587
2021
Q4
$959K Buy
119,896
+3,302
+3% +$26.4K ﹤0.01% 4609
2021
Q3
$1.39M Sell
116,594
-1,566
-1% -$18.6K ﹤0.01% 4403
2021
Q2
$1.83M Sell
118,160
-282,536
-71% -$4.38M ﹤0.01% 4240
2021
Q1
$9.62M Buy
400,696
+17,649
+5% +$424K ﹤0.01% 3538
2020
Q4
$11.3M Buy
383,047
+31,875
+9% +$940K ﹤0.01% 3233
2020
Q3
$5.37M Buy
351,172
+3,642
+1% +$55.7K ﹤0.01% 3454
2020
Q2
$8.69M Buy
347,530
+22,373
+7% +$559K ﹤0.01% 3198
2020
Q1
$6.63M Sell
325,157
-3,358
-1% -$68.5K ﹤0.01% 3160
2019
Q4
$10.2M Buy
328,515
+5,027
+2% +$155K ﹤0.01% 3202
2019
Q3
$10.8M Buy
323,488
+12,381
+4% +$414K ﹤0.01% 3133
2019
Q2
$9.96M Buy
311,107
+37,296
+14% +$1.19M ﹤0.01% 3225
2019
Q1
$7.86M Sell
273,811
-9,882
-3% -$284K ﹤0.01% 3200
2018
Q4
$11.4M Sell
283,693
-2,171
-0.8% -$87.3K ﹤0.01% 3001
2018
Q3
$13.4M Buy
285,864
+14,430
+5% +$674K ﹤0.01% 3063
2018
Q2
$22.3M Buy
271,434
+233,234
+611% +$19.2M ﹤0.01% 2770
2018
Q1
$1.59M Sell
38,200
-409
-1% -$17.1K ﹤0.01% 3703
2017
Q4
$1.25M Buy
38,609
+9,498
+33% +$308K ﹤0.01% 3781
2017
Q3
$515K Sell
29,111
-312
-1% -$5.52K ﹤0.01% 3987
2017
Q2
$309K Buy
29,423
+1,801
+7% +$18.9K ﹤0.01% 4085
2017
Q1
$392K Buy
+27,622
New +$392K ﹤0.01% 3983